Premium
Should glycoprotein IIb/IIIa inhibitors be used during all percutaneous coronary interventions? No
Author(s) -
Ragosta M.,
Sarembock I. J.
Publication year - 2004
Publication title -
journal of thrombosis and haemostasis
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.947
H-Index - 178
eISSN - 1538-7836
pISSN - 1538-7933
DOI - 10.1111/j.1538-7836.2004.00560.x
Subject(s) - medicine , abciximab , conventional pci , adjunctive treatment , aspirin , bolus (digestion) , heparin , pharmacology , percutaneous coronary intervention , antithrombin , regimen , myocardial infarction